Speratum Competitors and Similar CompaniesClear all
Speratum's competitors and similar companies include Foghorn Therapeutics and Neovii.
 Speratum Speratum is a biotechnology company developing targeted molecular therapies for the treatment of cancer. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
| |
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2003 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations HQ | Locations Cambridge, US HQ Cambridge, US | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US |
Employees | Employees 9 | Employees 1123% decrease | Employees 1193% increase |
Funding | |||
Total funding raised | Total funding raised $ 2.8m | Total funding raised $ 50m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyNeovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View company